These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12489614)

  • 1. Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia.
    Taussig J; Junge B; Burris S; Jones TS; Sterk CE
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S40-5. PubMed ID: 12489614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado.
    Lewis BA; Koester SK; Bush TW
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S46-51. PubMed ID: 12489615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
    Wright-De Agüero L; Weinstein B; Jones TS; Miles J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users.
    Blumenthal WJ; Springer KW; Jones TS; Sterk CE
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S34-9. PubMed ID: 12489613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
    Coffin PO; Linas BP; Factor SH; Vlahov D
    J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' attitudes and practices about selling syringes to people who inject drugs in Tajikistan: Results of a syringe purchase audit and a survey.
    Ibragimov U; Haardörfer R; Cooper HLF; Dunkle KL; Zule WA; Wong FY
    Int J Drug Policy; 2019 Sep; 71():62-72. PubMed ID: 31226505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study.
    Fedorova EV; Skochilov RV; Heimer R; Case P; Beletsky L; Grau LE; Kozlov AP; Shaboltas AV
    BMC Public Health; 2013 Mar; 13():183. PubMed ID: 23452390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.
    Case P; Beckett GA; Jones TS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S94-101. PubMed ID: 9663631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island.
    Rich JD; Martin EG; Macalino GE; Paul RV; McNamara S; Taylor LE
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S58-61. PubMed ID: 12489617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws.
    Gleghorn AA; Gee G; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S89-93. PubMed ID: 9663630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection drug users report good access to pharmacy sale of syringes.
    Reich W; Compton WM; Horton JC; Cottler LB; Cunningham-Williams RM; Booth R; Singer M; Leukefeld C; Fink J; Stopka TJ; Corsi KF; Tindall MS
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S68-72. PubMed ID: 12489619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The legality of selling or giving syringes to injection drug users.
    Burris S; Vernick JS; Ditzler A; Strathdee S
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S13-8. PubMed ID: 12489604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
    Pollini RA
    J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon.
    Ghaddar A; Nassar K; Elsoury G
    Subst Use Misuse; 2017 Sep; 52(11):1420-1428. PubMed ID: 28430013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention.
    Zaller ND; Yokell MA; Apeakorang N; Gaggin J; Case P
    J Health Care Poor Underserved; 2012 Aug; 23(3):1310-26. PubMed ID: 24212176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
    Lurie P; Jones TS; Foley J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S45-51. PubMed ID: 9663623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist ambivalence about sale of syringes to injection drug users.
    Reich W; Compton WM; Horton JC; Cottler LB; Cunningham-Williams RM; Booth R; Singer M; Leukefeld C; Fink J; Stopka T; Corsi KF; Tindall MS
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S52-7. PubMed ID: 12489616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community Impact of Pharmacy-Randomized Intervention to Improve Access to Syringes and Services for Injection Drug Users.
    Crawford ND; Amesty S; Rivera AV; Harripersaud K; Turner A; Fuller CM
    Health Educ Behav; 2014 Aug; 41(4):397-405. PubMed ID: 24722219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.
    Zaller N; Jeronimo A; Bratberg J; Case P; Rich JD
    J Urban Health; 2010 Dec; 87(6):942-53. PubMed ID: 21116724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.
    Taussig JA; Weinstein B; Burris S; Jones TS
    AIDS; 2000 Jun; 14 Suppl 1():S47-51. PubMed ID: 10981474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.